Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection

Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection

BackgroundWhether or not a single-dose Ad26.COV2.S prime and boost vaccination induces sufficient immunity is unclear. Concerns about the increased risk of breakthrough infections in the Ad26.COV2.S-primed population have also been raised.MethodsA prospective cohort study was conducted. Participants...

Full description

Bibliographic Details
Main Authors:	Hakjun Hyun, A-Yeung Jang, Heedo Park, Jung Yeon Heo, Yu Bin Seo, Eliel Nham, Jin Gu Yoon, Hye Seong, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim, Soo-Young Yoon, Jong Hyeon Seok, Jineui Kim, Man-Seong Park, Joon Young Song
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Immunology
Subjects:	SARS-CoV-2 COVID-19 vaccines humoral immunity cellular immunity booster
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1131229/full

Similar Items

Clinical implications of gut microbiota and cytokine responses in coronavirus disease prognosis
by: Hye Seong, et al.
Published: (2023-03-01)

Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
by: Eliel Nham, et al.
Published: (2023-12-01)

Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes.
by: Hakjun Hyun, et al.
Published: (2022-01-01)

Safe hospital preparedness in the era of COVID-19: The Swiss cheese model
by: Ji Yun Noh, et al.
Published: (2020-09-01)

Neutralizing Activity against BQ.1.1, BN.1, and XBB.1 in Bivalent COVID-19 Vaccine Recipients: Comparison by the Types of Prior Infection and Vaccine Formulations
by: Hak-Jun Hyun, et al.
Published: (2023-08-01)

Seroepidemiologic survey of emerging vector-borne infections in South Korean forest/field workers.
by: Ji Yun Noh, et al.
Published: (2021-08-01)

Effectiveness of Antiviral Therapy on Long COVID: A Systematic Review and Meta-Analysis
by: Yu Jung Choi, et al.
Published: (2023-11-01)

Comparison of the second and third waves of the COVID-19 pandemic in South Korea: Importance of early public health intervention
by: Hye Seong, et al.
Published: (2021-03-01)

Correlation between the Level of Social Distancing and Activity of Influenza Epidemic or COVID-19 Pandemic: A Subway Use-Based Assessment
by: Hye Seong, et al.
Published: (2021-07-01)

Effects of influenza immunization on pneumonia in the elderly
by: Jung Yeon Heo, et al.
Published: (2018-03-01)

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults in the era of highly active antiretroviral therapy: analysis stratified by CD4 T-cell count
by: Joon Young Song, et al.
Published: (2020-01-01)

Seroprevalence and disease burden of acute hepatitis A in adult population in South Korea.
by: Jin Gu Yoon, et al.
Published: (2017-01-01)

Collection and detection of SARS-CoV-2 in exhaled breath using face mask.
by: Hwang-Soo Kim, et al.
Published: (2022-01-01)

COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19
by: Jung Yeon Heo, et al.
Published: (2022-09-01)

Development and Validation of Enzyme-Linked Immunosorbent Assay for Group B Streptococcal Polysaccharide Vaccine
by: A-Yeung Jang, et al.
Published: (2021-05-01)

Age-stratified analysis of serotype-specific baseline immunity against group B streptococcus
by: Min Joo Choi, et al.
Published: (2020-06-01)

Immunogenicity and safety of a tetanus-diphtheria vaccine and a 13-valent pneumococcal conjugate vaccine after concomitant vaccination in ≥ 50-year-old adults
by: Joon Young Song, et al.
Published: (2018-12-01)

Metformin reduces the risk of developing influenza A virus related cardiovascular disease
by: Han Sol Lee, et al.
Published: (2023-10-01)

How lessons learned from the 2015 Middle East respiratory syndrome outbreak affected the response to coronavirus disease 2019 in the Republic of Korea
by: Tae Un Yang, et al.
Published: (2021-03-01)

Gut microbiota as a potential key to modulating humoral immunogenicity of new platform COVID-19 vaccines
by: Hye Seong, et al.
Published: (2023-05-01)

Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial
by: Joon-Young Song, et al.
Published: (2021-08-01)

Six-month longitudinal immune kinetics after mRNA-1273 vaccination: Correlation of peak antibody response with long-term, cross-reactive immunity
by: Min Joo Choi, et al.
Published: (2023-01-01)

Molecular Epidemiology of Human Adenovirus–Associated Febrile Respiratory Illness in Soldiers, South Korea
by: Jung Yeon Heo, et al.
Published: (2018-07-01)

Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
by: Eunju Shin, et al.
Published: (2023-07-01)

Randomized, double-blind, multi-center, phase III clinical trial to evaluate the immunogenicity and safety of MG1109 (egg-based pre-pandemic influenza A/H5N1 vaccine) in healthy adults
by: Joon Young Song, et al.
Published: (2017-05-01)

Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching.
by: Joon Young Song, et al.
Published: (2018-01-01)

Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis.
by: Jung Yeon Heo, et al.
Published: (2018-01-01)

Longitudinal immune kinetics of COVID-19 booster versus primary series vaccination: Insight into the annual vaccination strategy
by: Min Joo Choi, et al.
Published: (2024-03-01)

Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study
by: Min Joo Choi, et al.
Published: (2021-01-01)

Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus
by: Min Joo Choi, et al.
Published: (2018-01-01)

Paradoxical long-term impact of maternal influenza infection on neonates and infants
by: Joon Young Song, et al.
Published: (2020-07-01)

Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adults
by: Joon Young Song, et al.
Published: (2019-03-01)

Impact of preceding flu-like illness on the serotype distribution of pneumococcal pneumonia.
by: Joon Young Song, et al.
Published: (2014-01-01)

Laboratory surveillance of influenza-like illness in seven teaching hospitals, South Korea: 2011-2012 season.
by: Ji Yun Noh, et al.
Published: (2013-01-01)

Disease burden of 2013-2014 seasonal influenza in adults in Korea.
by: Won Suk Choi, et al.
Published: (2017-01-01)

Environmental factors which can affect the burden of pneumococcal disease and the immune response to pneumococcal vaccines: the need for more precisely delineated vaccine recommendations
by: Seong-Beom Park, et al.
Published: (2019-06-01)

Effects of Alzheimer’s and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer’s Disease
by: Wha Jin Lee, et al.
Published: (2021-02-01)

Establishment of a human embryonic stem cell line, WAe009-A-99, with constitutive expression of the dCas9-p300 fusion protein
by: Eun-Hye Kang, et al.
Published: (2023-02-01)

The attenuation of neurological injury from the use of simvastatin after spinal cord ischemia-reperfusion injury in rats
by: Jung-Hee Ryu, et al.
Published: (2018-03-01)

Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects
by: Won Suk Choi, et al.
Published: (2017-07-01)